Professionally managed funds do not short their positions on successful trials ie (1503 Ph2 trial), only simple retail investors do, who are part time investors with no buy strategy or sell strategy!! Instos have medium- long-term positions, they are not traders, they are value investors, their criteria is fundamentals... they invested into BOT because of the serially successfully management team and the proven efficacy/safety profile of CBD proven via various 1b trials, dont forget permatrex etc!!. This is a world-first company:
Professionally managed funds do not short their positions on...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
0.015(5.56%) |
Mkt cap ! $448.9M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 29.5¢ | 27.0¢ | $1.789M | 6.392M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 29995 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 6507 | 1 |
View Market Depth
| Last trade - 16.10pm 20/05/2024 (20 minute delay) ? |
|
|||||
|
Last
29.0¢ |
Change
0.015 ( 7.41 %) |
||||
| Open | High | Low | Volume | ||
| 27.5¢ | 29.5¢ | 27.0¢ | 1370780 | ||
| Last updated 15.59pm 20/05/2024 ? | |||||
| BOT (ASX) Chart |